Mucoadhesive in situ nasal gel of amoxicillin trihydrate for improved local delivery: ex vivo mucosal permeation and retention studies

Mardikasari, Sandra Aulia and Katona, Gábor and Budai-Szűcs, Mária and Kiricsi, Ágnes and Rovó, László and Pannonhalminé Csóka, Ildikó (2024) Mucoadhesive in situ nasal gel of amoxicillin trihydrate for improved local delivery: ex vivo mucosal permeation and retention studies. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 202. No.-106897. ISSN 0928-0987

Preview	Text 1-s2.0-S0928098724002094-main.pdf - Published Version Available under License Creative Commons Attribution Non-commercial. Download (4MB) | Preview
Preview	Text (graphical abstract) 1-s2.0-S0928098724002094-ga1_lrg.jpg - Published Version Available under License Creative Commons Attribution Non-commercial. Download (351kB) | Preview

Abstract

Orally administered amoxicillin is recommended as the first-line treatment of acute bacterial rhinosinusitis (ABR) and given in a high-dose regimen. However, the risk of various systemic adverse reactions and low oral bioavailability are unbearable, increasing the threat of antibiotic resistance. Therefore, nasal delivery of amoxicillin can be a potential approach for effectively treating ABR locally, as well as overcoming those drawbacks. In a way to guarantee the effectiveness for local therapy in nasal cavity, the permeation and retention properties are of significant importance considerations. Accordingly, the present work aimed to investigate the characteristics with respect to the nasal applicability of the in situ gelling amoxicillin trihydrate (AMT) and further evaluate its permeability and retention properties through human nasal mucosa. The lyophilized formulations were characterized utilizing the Differential Scanning Calorimetry (DSC) and X-ray Powder Diffraction (XRPD), and also evaluated for its polarity, reconstitution time, droplet size distribution, mucoadhesive properties, and ex vivo permeability and retention studies. The results confirmed that the in situ gelling AMT formulations possess adequate mucoadhesive behavior, especially the formulation containing 0.3 % of gellan gum. Substantially, the in situ gelling AMT formulations were able to retain the drug on the surface of nasal mucosa instead of permeating across the membrane; thus, suitable for treating nasal infections locally. Altogether, the in situ gelling systems demonstrates promising abilities as a delivery platform to enhance local application of AMT within the nasal cavity.

Actions (login required)

Edit Item